IRIS Accounts Production v24.3.0.553 01945726 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh019457262023-03-31019457262024-03-31019457262023-04-012024-03-31019457262022-03-31019457262022-04-012023-03-31019457262023-03-3101945726ns15:EnglandWales2023-04-012024-03-3101945726ns14:PoundSterling2023-04-012024-03-3101945726ns10:Director12023-04-012024-03-3101945726ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3101945726ns10:SmallEntities2023-04-012024-03-3101945726ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3101945726ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3101945726ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3101945726ns10:FullAccounts2023-04-012024-03-3101945726ns10:Director22023-04-012024-03-3101945726ns10:Director32023-04-012024-03-3101945726ns10:Director42023-04-012024-03-3101945726ns10:CompanySecretary12023-04-012024-03-3101945726ns10:RegisteredOffice2023-04-012024-03-3101945726ns5:CurrentFinancialInstruments2024-03-3101945726ns5:CurrentFinancialInstruments2023-03-3101945726ns5:Non-currentFinancialInstruments2024-03-3101945726ns5:Non-currentFinancialInstruments2023-03-3101945726ns5:ShareCapital2024-03-3101945726ns5:ShareCapital2023-03-3101945726ns5:RetainedEarningsAccumulatedLosses2024-03-3101945726ns5:RetainedEarningsAccumulatedLosses2023-03-3101945726ns5:LandBuildings2023-04-012024-03-3101945726ns5:PlantMachinery2023-04-012024-03-3101945726ns5:LandBuildings2023-03-3101945726ns5:PlantMachinery2023-03-3101945726ns5:LandBuildings2024-03-3101945726ns5:PlantMachinery2024-03-3101945726ns5:LandBuildings2023-03-3101945726ns5:PlantMachinery2023-03-3101945726ns5:CostValuation2023-03-3101945726ns5:AdditionsToInvestments2024-03-3101945726ns5:CostValuation2024-03-3101945726ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3101945726ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 01945726 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2024

for

B.S.B. Pharmacy Limited

B.S.B. Pharmacy Limited (Registered number: 01945726)

Contents of the Financial Statements
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


B.S.B. Pharmacy Limited

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Mr Sundeep Singh Ubhi
Mr Makhan Singh Ubhi
Mr Karanjeet Singh Ubhi
Mrs Amrit Pal Ubhi





SECRETARY: Mrs Amrit Pal Ubhi





REGISTERED OFFICE: 71a Walsall Road
Little Aston
Sutton Coldfield
West Midlands
B74 3BA





REGISTERED NUMBER: 01945726 (England and Wales)





ACCOUNTANTS: Dhillon Accountants Limited
Chartered Accountants
Office 1
21 Hatherton Street
Walsall
WS4 2LA

B.S.B. Pharmacy Limited (Registered number: 01945726)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 229,119 250,281
Investments 5 10,100 8,100
239,219 258,381

CURRENT ASSETS
Stocks 106,444 95,194
Debtors 6 273,238 254,103
Cash at bank and in hand 115,970 83,662
495,652 432,959
CREDITORS
Amounts falling due within one year 7 (311,461 ) (293,655 )
NET CURRENT ASSETS 184,191 139,304
TOTAL ASSETS LESS CURRENT
LIABILITIES

423,410

397,685

CREDITORS
Amounts falling due after more than
one year

8

(10,986

)

(21,564

)
NET ASSETS 412,424 376,121

CAPITAL AND RESERVES
Called up share capital 800 800
Retained earnings 411,624 375,321
SHAREHOLDERS' FUNDS 412,424 376,121

B.S.B. Pharmacy Limited (Registered number: 01945726)

Balance Sheet - continued
31 March 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 November 2024 and were signed on its behalf by:





Mr Makhan Singh Ubhi - Director


B.S.B. Pharmacy Limited (Registered number: 01945726)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

B.S.B. Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - Straight line over 25 years
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2023 - 14 ) .

B.S.B. Pharmacy Limited (Registered number: 01945726)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2023 316,934 198,018 514,952
Additions - 1,814 1,814
At 31 March 2024 316,934 199,832 516,766
DEPRECIATION
At 1 April 2023 106,663 158,008 264,671
Charge for year 12,678 10,298 22,976
At 31 March 2024 119,341 168,306 287,647
NET BOOK VALUE
At 31 March 2024 197,593 31,526 229,119
At 31 March 2023 210,271 40,010 250,281

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 April 2023 8,100
Additions 2,000
At 31 March 2024 10,100
NET BOOK VALUE
At 31 March 2024 10,100
At 31 March 2023 8,100

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 216,961 202,296
Other debtors 56,277 51,807
273,238 254,103

B.S.B. Pharmacy Limited (Registered number: 01945726)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Bank loans and overdrafts 10,044 10,200
Trade creditors 240,311 254,641
Amounts owed to group undertakings 18,872 18,872
Taxation and social security 34,152 7,108
Other creditors 8,082 2,834
311,461 293,655

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.3.24 31.3.23
£    £   
Bank loans 10,986 21,564

9. RELATED PARTY DISCLOSURES

As of 31 March 2024, the company was owed £16,199.79 (2023 - £14,495.52) by MAKS Chemist Ltd and owed £18,872.02 (2023 - £18,872.02) to Ubhi Pharmacy Ltd.
Mrs Amrit Pal Ubhi, Mr Karanjeet Singh Ubhi, Mr Makhan Singh Ubhi & Mr Sundeep Singh Ubhi were the directors of Ubhi Pharmacy Ltd and MAKS Chemist Ltd as of 31 March 2024.